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Enhancing Osteogenic Differentiation of Mouse
Embryonic Stem Cells by Nanofibers
Laura A. Smith, M.S.,1 Xiaohua Liu, Ph.D.,2 Jiang Hu, Ph.D.,2
Peng Wang, Ph.D.,2 and Peter X. Ma, Ph.D.1–3
Controlled differentiation of embryonic stem cells (ESC) is necessary to their use as a cell source for tissue
engineering or regeneration. To date, most studies have concentrated on chemical cues to direct ESC differen-
tiation. However, during normal embryonic development, multiple factors beyond chemical cues play a role,
including the extracellular matrix (ECM) in bone development. In this study, we use nanofibrous (NF) matrices
to mimic the morphology of the ECM to examine the contribution of the ECM morphology to the differentiation
of mouse ESC. After 12 h of differentiation culture, mouse ESC form protrusions interacting with NF matrices,
while they appear not to interact with flat films. Immunofluorescence staining after 26 days of differentiation
culture indicates a greater degree of differentiation for mouse ESC on NF matrices compared to flat films.
Polymerase chain reaction results, also, show greater degree of osteogenic differentiation on NF matrices
compared to flat films when osteogenic supplements are added to the culture. Overall, these results demonstrate
that NF morphology contributes to the controlled differentiation of mouse ESC.
Introduction
Embryonic stem cells (ESC) typically isolated from theinner cell mass of blastocysts are pluripotent and possess
the ability to differentiate into all tissues derived from the
three germ layers.1,2 Due to this, ESC hold great promise as a
cell source for tissue engineering.3 Additionally, ESC have
been found to proliferate longer than other types of stem
cells, making them a potentially advantageous cell source.
ESC-derived cells have just begun to be explored as the cell
source for tissue engineering applications.4–7
Much of the effort to control the differentiation of ESC into
specific lineages has focused on the use of biological factors.8–10
However, it is known that extracellular matrix (ECM) con-
tributes to the osteogenic lineage selection during embryonic
development through cytoskeletal and surface receptor inter-
actions.11–13 Therefore, to successfully use ESC in tissue engi-
neering, we need to understand and mimic the contributions
of the ECM. The scaffold should act as a directive template for
the ESC, stimulating the desired differentiation pathway much
as the ECM does during embryonic development. As such, the
scaffold should mimic the natural ECM of the desired tissue.14
Type I collagen, consisting of three collagen polypeptide
chains wound together to form a ropelike superhelix that as-
sembles into the fibers ranging in size from 50 to 500 nm,15,16 is
a major component of the ECM in many tissues.
We hypothesize that such nanofibers advantageously
support ESC differentiation because they provide a micro-
environment for cells more similar to the type 1 collagen
ECM than traditional smooth surfaces. Synthetic three-
dimensional nanofibers of the same size scale as natural type
I collagen have been developed in our lab using a novel phase
separation technique.17–21 To test our hypothesis, thin
poly(L-lactic acid) (PLLA) matrices with nanofibrous (NF)
architecture and flat (solid) films were used as a model system
to study the effects of scaffold wall architecture on the dif-
ferentiation of mouse ESC to osteoblastic lineage as a pre-
cursor to their use as a cell source for bone tissue engineering.
Materials and Methods
Materials
PLLA with an inherent viscosity of 1.6 dL=g was pur-
chased from Alkermes (Medisorb; Cambridge, MA) and
used without further purification. Dulbecco’s modified Ea-
gle’s media (DMEM), 0.5 M EDTA, trypsin, Hank’s buff-
ered salt solution, and polymerase chain reaction (PCR)
primers were obtained from Invitrogen (Carlsbad, CA). Fetal
bovine serum (FBS) was obtained from Harlan Biological
(Indianapolis, IN). Human recombinant leukemia inhibi-
tory factor (LIF) and Neuronal Class III b-Tubulin (TUJ1)
antibody were obtained from Chemicon (Temecula, CA).
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Brachyury antibody was obtained from Santa Cruz Bio-
technology (Santa Cruz, CA). LEAF anti-mouse=rat CD49e,
LEAF anti-mouse=rat CD49b, and LEAF Purified Armenian
Hamster Immunoglobulin G (IGG) Isotype Control were
obtained from Biolegend (San Diego, CA). All secondary
antibodies and normal donkey serum were obtained from
Jackson ImmunoResearch (West Grove, PA). RNeasy Mini
Kit and Rnase-Free DNase set were obtained from Qiagen
(Valencia, CA). TaqMan reverse transcription reagents, real-
time PCR primers, and TaqMan Universal PCR Master Mix
were obtained from Applied Biosystems (Foster City, CA).
Chemicals were obtained from Sigma Chemical (St. Louis,
MO) unless otherwise noted above.
Thin matrix preparation for cell culture
PLLA was dissolved in tetrahydrofuran at 608C to make a
10% (w=v) PLLA solution. The NF PLLA matrix (thickness
*40 mm) was fabricated by first casting 0.4 mL of the PLLA
solution on a glass support plate that had been preheated at
458C for 10 min and then sealing the polymer solution on the
glass support plate by covering it with another preheated
glass plate. The polymer solution was phase separated at
208C for 2 h and then immersed into a mixture of ice and
water to exchange tetrahydrofuran for 24 h. The matrix was
washed with distilled water at room temperature for 24 h
with water changed every 8 h. The matrix was then freeze-
dried. The porosity and fiber diameter were determined as
previously described.17 Briefly, the volume and the weight of
the matrix were determined, and then the density was cal-
culated. The porosity was then calculated from the measured
overall densities. The average fiber diameter was calculated
from scanning electron microscopy (SEM) micrographs. Fifty
fibers per sample were measured, and their average and
standard deviations are reported.
The matrices were cut to fit into a 35-mm Petri dish and
secured in place with a disk of silicone elastomer from Dow
Corning (Midland, MI) containing a 1.5 mm by 1.5 mm
opening that had been cast from a 1:10 mix of curing agent to
base. The matrices were then sterilized with ethylene oxide,
wet with Hank’s buffered salt solution two times for 0.5 h
each, and rinsed with differentiation media (DMEM sup-
plemented with 20% FBS, 104 M b-mercaptoethanol, and
1.33 mg=mL HEPES) for 1 h.
Solid films were fabricated in a similar manner excluding
the phase separation step. Instead, the solvent was evapo-
rated at room temperature in a fume hood. The flat films and
0.1% gelatin-coated Petri dishes were then treated similarly
to the NF matrices.
Mouse ESC culture and seeding
D3 mouse ESC22 were cultured on 0.1% gelatin-coated
tissue culture flasks in ESC media (DMEM supplemented
with 10% FBS, 104 M b-mercaptoethanol, 0.224mg=mL
L-glutamine, 1.33 mg=mL HEPES, and 1000 units=mL human
recombinant LIF).
Fifteen thousand (for SEM to see the interactions of indi-
vidual cells with the matrices) or 60,000 cells were seeded on
each of the prepared matrices or 0.1% gelatin-coated tissue
culture dish controls. Upon seeding, cells were cultured in
differentiation media (DMEM supplemented with 20% FBS,
104 M b-mercaptoethanol, 0.224mg=mL L-glutamine, and
1.33 mg=mL HEPES) or osteogenic media (differentiation
media supplemented with 1mM dexamethasone, 50mg=mL
ascorbic acid, and 10 mM b-glycerol phosphate). The media
was changed 12 h after seeding and then every other day for
the remainder of the culture period.
For the a2 integrin blocking studies, 6mg=mL LEAF anti-
mouse=rat CD49b antibody23 was added to the media from
day 7 onward, while for the a5 integrin blocking studies
6 mg=mL LEAF anti-mouse=rat CD49e antibody was added
to the media after a 24 h attachment period.
Scanning electron microscopy
Twelve hours after seeding, the matrices and control were
washed with phosphate-buffered saline (PBS) and 0.1 M ca-
codylate buffer, and then fixed with 2.5% glutaraldehyde in
0.1 M cacodylate buffer over night. The matrices were washed
again with 0.1 M cacodylate buffer and postfixed in 1% os-
mium tetroxide for 1 h. The fixed samples were then dehy-
drated through an ethanol gradient (50%, 70%, 90%, 95%, and
100%) over 3 h and dried with hexamethyldisilazane. Samples
were then gold coated and observed using SEM (S-3200;
Hitachi, Tokyo, Japan). Cell spreading area was calculated
from at least 20 cells per sample in the SEM images using the
automated measure function of ImageJ (downloaded from the
National Institutes of Health, Bethesda, MD; free download
available at http:==rsb.info.nih.gov=ij=).
Immunofluorescence and Alizarin Red S staining
For quantitative analysis, the ESC were removed from the
matrices and 0.1% gelatin-coated tissue culture plastic con-
trol using 0.25% trypsin=1 mM EDTA. The cells were then
fixed with 4% paraformaldehyde=0.2% triton-X100 in PBS,
washed twice in 0.1% goat serum in PBS, and stained in
1 mg of Runx2 and TUJ1 antibodies in 100 mL of 0.2%
Triton-X100= 2% goat serum in PBS. The ESC were then
washed twice with PBS and stained with the appropriate
secondary antibodies and DAPI. The cells from each 12-day
sample were then placed on a cover slip, and the number of
ESC expressing Runx2 and TUJ1 were then counted in four
random fields of view in each of three replicates. At least
900 cells as determined by DAPI staining in images taken
with an RT Slider Spot Camera (Diagnostic Instraments,
Sterling Heights, MI) on an Eclispe TE 300 fluorescence
microscope (Nikon Instruments, Melville, NY) were counted
per sample using Image-Pro Plus (Media Cybernetics, Be-
thesda, MD). Images of Runx2 and TUJ1 staining were
overlaid with matching images of DAPI staining in Photo-
shop CS (Adobe, San Jose, CA). Areas of Runx2 and TUJ1
staining not associated with a nucleus were then manually
excluded in Image-Pro Plus. All counts were checked with a
counter by hand and found to be similar.
After 26 days of culture, the matrices and controls were
fixed with 2% paraformaldehyde=PBS, washed, and stored
at 48C in PBS. Nonspecific antibody binding was blocked by
incubating in 10% donkey or goat serum, and then the ma-
trices and controls were exposed to TUJ1 (1:250) or osteo-
calcin (1:50) antibodies, followed by appropriate secondary
antibodies conjugated to FITC (TUJ1), or TRITC (osteo-
calcin). DAPI was used to stain cell nuclei.
For Alizarin Red S staining, the matrices and controls were
fixed using the same method as described above and then
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stained with 40 mM Alizarin Red S solution, pH 4.2 at room
temperature for 10 min. Matrices and controls were then
rinsed five times in distilled water and washed three times in
PBS on an orbital shaker at 40 rpm for 5 min each to reduce
nonspecific binding.
Western blotting
Films were prewetted with PBS according to protocol de-
scribed above, and then cell culture medium or 100mg=mL
bovine fibronectin was added and incubated for 1 h. For cell
culture medium treatment, three films were pooled for sam-
ple collection, while one film was used to form fibronectin
collection sample. Films were then washed with PBS for two
times, cut into pieces, and transferred to 1.5 mL tubes. One
milliliter of PBS was added, and the films were washed three
times. PBS was then removed, and the films were centrifuged
at 12,000 rpm for two times (1 min each) to remove remaining
liquid. One hundred microliters of 1% sodium dodecyl sul-
phate was added and incubated for 1 h. This was repeated
two more times, and the samples were pooled to form a 300mL
sample. Thirty microliters of the collection sample was used
for each gel. Western blot analysis was conducted as previ-
ously described.19 Briefly, the recovered serum protein sam-
ples were subject to fractionation through 4–12% sodium
dodecyl sulphate–polyacrylamide gel electrophoresis. The
fractionated proteins were transferred to a polyvinylidene
fluoride (PVDF) membrane (Sigma). The blots were washed
with Tris-Buffered Saline=TWEEN-20 (TBST) (10 mM Tris-
HCl, 150 mM NaCl, and 0.05% Tween-20, pH 8.0), and
blocked with Blotto (5% nonfat milk in TBST) at room tem-
perature for 1 h. The blots were incubated in anti-bovine fi-
bronectin polyclonal antibody (Santa Cruz Biotechnology) at
room temperature for 1 h. After washing with TBST, the blots
were incubated in anti-goat IGG-horseradish peroxidase–
conjugated antibody (Sigma), and then in chemiluminescence
reagent (SuperSignal West Dura; Pierce, Rockford, IL). The
relative densities of the protein bands were analyzed with
QualityOne (Biorad, Hercules, CA).
PCR and real-time PCR
Total RNA was isolated from at least three replicates using
an RNeasy Mini Kit according to the manufacturer’s protocol
after films were mechanically homogenized with a Tissue-
Tearor (BioSpec Products, Bartlesville, OK), while cells cul-
tured on gelatin-coated tissue culture plate controls were
harvested with a cell scraper. RNA samples with an optical
density ratio of absorbance at 260 nm (RNA) over that at
280 nm (protein) greater than 1.6 were used to make cDNA.
Based on the absorbance reading at 260 nm, 1 mg of RNA
from each sample was used to make cDNA using a Geneamp
PCR (Applied Biosystems) with TaqMan reverse transcription
reagents. The thermocycler program was as follows: 10 min
incubation at 258C, 30 min reverse transcription at 488C, and
5 min inactivation at 958C. Five microliters of each reaction
was subject to PCR using AmpliTaq Gold DNA polymerase
(Applied Biosystems) for each of the following: brachyury (50-
gctgtgactgcctaccagcagaatg-30 and 50-gagagagagcgagcctccaaac-
30); nestin (50-gtgcctctggatgatg-30 and 50-ttgaccttcctccccctc-30); a5
integrin (50-cgttgagtcattcgcctct-30 and 50-ctaccgcgtctaggttgaagc-
30); a2 integrin (50-acccgccccttctgtatcttt-30 and 50-ggcagtcatagcca
acagcaa-30); b1 integrin (50-ggtgtcgtgtttgtgaatgc-30 and 50-caca
gttgtcacggcactct-30); collagen type I (50-gaagtcagctgcatacac-30
and 50-aggaagtccaggctgtcc-30); Runx2 (50-ccgcacgacaaccgcaccat-
30 and 50-cgctccggcccacaaatctc-30); bone sialoprotein (50-gtca
acggcaccagcaccaa-30 and 50-gtagctgtattcgtcctcat-30); osteocalcin
(50-cggccctgagtctgacaaa-30 and 50-accttattgccctcctgcctt-30); and b
actin (50-caggattccatacccaagaag-30 and 50-aaccctaaggccaaccgtg-
30). The cycling conditions were 948C for 5 min followed by 948C
for 30 s, 558C for 60 s, 728C for 60 s 35 cycles for brachyury and b
actin, 948C for 120 s, 558C for 30 s, 728C for 45 s 35 cycles for
nestin, 948C for 60 s, 608C for 120 s, 728C for 180 s 40 cycles for
a5 integrin, and 948C for 30 s, 558C for 60 s, 728C for 60 s 30 cycles
for a2 integrin, b1 integrin, Runx2, bone sialoprotein, and os-
teocalcin. These amplifications were followed by a 10 min ex-
tension at 728C. The relative densities of the bands were
analyzed with QualityOne (Biorad) to obtain a semi-quantitative
assessment.
Real-time PCR was set up using TaqMan Universal PCR
Master mix and specific primer sequence for brachyury,
nestin, bone sialoprotein, osteocalcin, and b actin with 2 min
incubation at 508C, a 10 min Taq Activation at 958C, and 50
cycles of denaturation for 15 s at 958C, followed by an ex-
tension for 1 min at 728C on an ABI Prism 7500 Real-Time
PCR System (Applied Biosystems). Target genes were nor-
malized against b actin using a relative standard curve.
Statistical analysis
All experiments were conducted at least three times. All
quantifiable data are reported with the means and standard
deviations. Student’s t-tests were performed where applica-
ble. Significance was set at p # 0.05.
Results
The surface characterization of the NF matrix (Fig. 1A)
and the solid film (Fig. 1B) via SEM shows the differences in
matrix architecture before cell culture. The NF matrix was
found to contain fibers ranging in diameter from 50 to
500 nm with an average fiber diameter of 148 21 nm
(standard deviation) and calculated to have a porosity of
92.9%. The NF matrix contains very small pores preventing
cellular penetration so that the effects of scaffold wall ar-
chitecture can be studied without complications from cell
distribution and mass transport conditions associated with
pore size and inter-pore connectivity. Figure 1C illustrates
the difference in cell morphology after 12 h of culture on NF
PLLA matrix, solid PLLA film, and control surface (gelatin-
coated tissue culture plastic). The differentiating ESC ex-
tended more processes on the NF matrix and spread to a
greater degree (278 56 mm2 reported as area standard
deviation) compared with ESC grown on either the solid film
(110 12mm2*, *indicates p< 0.05 compared to NF matrix) or
control surface (203 26 mm2). Measurements of DNA con-
tent indicate that a similar number of cells have attached to
each of the materials (data not shown), indicating that the
cell morphology difference is not an effect of additional
surface area available on the NF matrices.
Based on these initial morphological differences on the
films, we examined cellular differentiation over longer culture
periods. Brachyury mRNA expression (a mesodermal marker)
and nestin (a neural marker) was examined in samples cul-
tured in osteogenic media for 12 days (Fig. 2A). ESC cultured
on the NF matrices were found to have increased brachyury
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expression and reduced nestin expression compared to those
on either the solid films or gelatin-coated control surface.
Quantitative PCR results for brachyury expression (Fig. 2B)
and nestin expression (Fig. 2C) show these relationships to be
significant.
Early osteogenic markers (type I collagen and Runx2)
were also examined via mRNA expression at day 12 (Fig.
2A). Type I collagen was found to be expressed more
strongly in the ESC on the NF matrix and control then those
on the solid films, while Runx2 was found to be expressed
more strongly in the ESC on the NF matrix than either of
those on the solid films or control. Later markers of bone
differentiation, bone sialoprotein and osteocalcin, were not
detectable at this time point.
Next, the percentage of cells on the matrices committed to
the osteogenic lineage was examined after 12 days of osteogenic
FIG. 2. Expression of
neuronal, mesodermal, and
early osteogenic markers
and integrins after 12 days
of culture under osteogenic
conditions. (A) PCR on NF
matrix (N), solid films (S),
and gelatin-coated tissue




solid films (Solid), and
gelatin-coated tissue
culture plastic (Control);
*p< 0.05. (C) Quantifica-






FIG. 1. SEM micrographs of (A) nanofibrous matrix, scale bar¼ 10 mm; (B) solid films, scale bar¼ 10mm; and (C) D3 cells
after 12 h under differentiation conditions on nanofibrous matrix (Nano), solid films (Solid), and gelatin-coated tissue culture
plastic (Control), scale bar¼ 5mm.
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culture. Approximately, 60 6% (expression standard de-
viation) of ESC on the NF matrices expressed Runx2 at this time
point, while only 33 11% of ESC on the solid films and
38 2% of ESC on the control. Expression of TUJ1, a neuronal
marker, was also examined at this time. Approximately,
37 11% (expression standard deviation) of ESC on the NF
matrices expressed TUJ1, while 61 13% of ESC on the solid
films and 35 10% of ESC on the control.
The expression of transcripts for several integrins (a2, a5,
and b1), cell membrane proteins that mediate cellular adhe-
sion to substrates, were also examined after 12 days of cul-
ture in osteogenic media (Fig. 2A). Several integrin subunits
associated with cellular adhesion to type I collagen (a2b1)
and fibronectin (a5b1) were found to be upregulated on the
NF matrices compared to the solid films. The increase in b1
integrin transcription in ESC on NF matrices compared to
solid films and control surface supports the lineage differ-
entiation data, as increased b1 integrin is associated with
increased mesodermal differentiation while inhibiting neu-
ronal differentiation.24 Because integrin expression varies
during osteogenesis as the ECM develops,25 the ESC on the
NF matrices may be changing their adhesion patterns and
therefore gene expression as a response to more developed
ECM being presented on the NF matrices than on either the
solid films or the control surface.
To examine the effects of a2 and a5 integrins on the
differentiation of ESC on the matrices, blocking studies
were conducted (Fig. 3). Because a2 integrin expression is
FIG. 3. Effects of integrin blocking on mesodermal and osteogenic differentiation after 12 days of differentiation culture. (A)
PCR of a2 integrin RNA expression over time on nanofibrous matrix (N) and flat (solid) films (S). (B) Quantitative PCR of
brachyury RNAs isolated from cells grown on nanofibrous matrix (Nano), on nanofibrous matrix with control IGG isotype
(IGG nano), on nanofibrous matrix with CD49b antibody (a2 blocking nano), on flat (solid) films (Solid), on flat (solid) films
with control IGG isotype (IGG solid), and on flat (solid) films with CD49b antibody (a2 blocking solid); **p< 0.01. (C)
Quantitative PCR of Runx2 RNAs isolated from cells grown on nanofibrous matrix (Nano), on nanofibrous matrix with
control IGG isotype (IGG nano), on nanofibrous matrix with CD49b antibody (a2 blocking nano), on solid-walled matrix
(Solid), on flat (solid) films with control IGG isotype (IGG solid), and on flat (solid) films with CD49b antibody (a2 blocking
Solid); **p< 0.01. (D) Quantitative PCR of brachyury RNAs isolated from cells grown on nanofibrous matrix (Nano), on
nanofibrous matrix with control IGG isotype (IGG nano), on nanofibrous matrix with CD49e antibody (a5 blocking nano), on
flat (solid) films (Solid), on flat (solid) films with control IGG isotype (IGG solid), and on solid-walled matrix with CD49e
antibody (a5 blocking solid); *p< 0.05. (E) Quantitative PCR of Runx2 RNAs isolated from cells grown on nanofibrous matrix
(Nano), on nanofibrous matrix with control IGG isotype (IGG nano), on nanofibrous matrix with CD49e antibody (a5
blocking nano), on solid-walled matrix (Solid), on flat (solid) films with control IGG isotype (IGG solid), and on flat (solid)
films with CD49e antibody (a5 blocking solid); *p< 0.05.
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developmentally regulated26 and not expressed at the mRNA
level in our undifferentiated cell population, a time course
was conducted to determine when a2 integrin mRNA begins
being transcribed during the differentiation process (Fig. 3A).
Because this does not occur until after day 7 of differentia-
tion, the blocking antibody was only administered to the
cells from day 7 onward in the study. Figure 3B shows that
blocking a2 integrin interactions substantially decrease me-
sodermal differentiation on both architectures. Runx2 was
also examined after blocking a2 integrin, but after 70 am-
plification cycles no Runx2 expression was found in the
samples treated with the a2 integrin blocking antibody,
while the samples treated with the IGG isotype control an-
tibody expressed Runx2 mRNA at a level similar to samples
not exposed to antibodies (Fig. 3C). Measurements of DNA
content indicate that a similar number of cells have attached
to each of the NF matrices and solid film samples regardless
of antibody treatment (data not shown), indicating that
changes in cellular differentiation are not the result of vari-
ations in cell number present on the samples. Because a2
integrin interactions have been found to be necessary for the
osteogenic differentiation of preosteoblasts, the lack of
Runx2 mRNA expression, a characteristic of a more com-
mitted cell type,23,27 in the samples where a2 integrin inter-
actions were blocked was not surprising. Because a5 integrin
is strongly expressed in our undifferentiated ESC,28 blocking
antibody was added to culture after a short attachment pe-
riod to block its additional stimulation of differentiation
signal transduction pathways such as focal adhesion kinase.
Blocking a5 integrin interactions has a significant effect on
both the mesodermal (Fig. 3D) and the osteogenic (Fig. 3E)
differentiation of ESC cultured on the NF matrices but little
effect on the mesodermal (Fig. 3D) and the osteogenic (Fig.
3E) differentiation of ESC cultured on the solid films. Be-
cause a5 integrin was downregulated at the mRNA level
(Fig. 2A) on the solid films compared to the NF matrices and
the effects of its stimulation on osteogenic differentiation
have been shown to be dependent on culture conditions,23,29
these results indicate that the NF matrices and the solid films
expose the ESC grown on them to different microenviron-
ments. One of the differences between the NF matrix and the
solid film appears to be associated with a5 integrin interac-
tions.
To examine the initial microenvironment created on each
architecture, the protein adsorption from the differentiation
media was examined (Fig. 4A). The NF matrices were found
to adsorb more protein than the solid films. Western blots for
fibronectin on NF matrices exposed to differentiation media
(Fig. 4B) or pure bovine fibronectin (Fig. 4C) were shown to
FIG. 4. Protein adsorption to materials after exposure to
differentiation media containing 20% bovine serum protein
or purified bovine fibronectin (100 mg=mL) for 1 h: (A) 4–12%
polyacrylamide gels stained with Coomassie blue from
protein extracts from nanofibrous matrix (N) and flat (solid)
films (S) treated with media; (B) Western blot of fibronectin
extracted from nanofibrous matrix (Nano) and flat (solid)
films (Solid) treated with media; (C) Western blot of fibro-
nectin extracted from nanofibrous matrix (Nano) and flat
(solid) films (Solid) treated with purified bovine fibronectin.
FIG. 5. Expression of osteogenic markers after 26 days of
culture under osteogenic differentiation conditions. (A) PCR
of RNAs isolated from cells grown on nanofibrous matrix
(N), flat (solid) films (S), and gelatin-coated tissue culture
plastic (C). (B) Quantitative PCR of osteocalcin RNAs iso-
lated from cells grown on nanofibrous matrix (Nano), flat
(solid) films (Solid), and gelatin-coated tissue culture plastic
(Control); **p< 0.01. (C) Quantitative PCR of bone sialopro-
tein RNAs isolated from cells grown on nanofibrous matrix
(Nano), flat (solid) films (Solid), and gelatin-coated tissue
culture plastic (Control); *p< 0.05 and **p< 0.01.
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adsorb more fibronectin than similarly treated solid films,
supporting the a5 integrin blocking data.
The expression of bone markers was examined after 26
days of differentiation (Fig. 5A). Type I collagen, unlike 12
days of differentiation, was expressed at a similar level on all
materials and controls. While after the additional culture
time, Runx2 was more strongly expressed on all materials
and controls, it was still expressed more strongly on NF
matrices than on solid films. Later markers of osteogenic
differentiation (bone sialoprotein and osteocalcin) were now
detected unlike the earlier time point. ESC grown on the NF
matrices expressed higher levels of osteocalcin (Fig. 5B) and
bone sialoprotein (Fig. 5C) compared to both solid films (3
times for both markers) and control surfaces (1.8 and 5.5
times, respectively).
The expression of these late-stage bone markers coincides
with the mineralization of the matrix during bone formation.
After 26 days of osteogenic culture, the samples were stained
for calcium to examine mineral deposition on each of the
surfaces (Fig. 6A). Although all the samples showed some
degree of calcium deposition, there was substantially more
calcium on the NF matrices than on the solid films or the
controls. NF matrix without cells cultured in media for the
same time period did not show significant staining (Fig. 6B),
signifying that the mineralization on the NF matrices is due
to cellular deposition and not biomimetic absorption from
the media. Immunohistochemical localization of osteocalcin
and TUJ1 was used to determine the distribution of the
mature osteoblasts across the matrices (Fig. 6C). NF matrices
had an even distribution of osteocalcin across the surface
with very little neuronal differentiation, while solid films
and controls had less osteocalcin protein and increased
neuronal differentiation. NF matrix controls either without
cells or without antibodies indicate that the staining is spe-
cific for osteocalcin and TUJ1 and not nonspecific binding of
the antibody to the NF matrix. In combination with the
FIG. 6. Mineralization and
extracellular characterization
after 26 days of culture under
osteogenic differentiation
conditions. (A) Calcium stain-
ing after 26 days under oste-
ogenic differentiation
conditions on nanofibrous
matrix (Nano), solid films
(Solid), and gelatin-coated tis-
sue culture plastic (Control).
(B) Calcium staining after 26
days under osteogenic differ-
entiation conditions on nano-
fibrous matrix without ESC.
(C) Immunofluorescence lo-
calization neuronal (TUJ1)
and late bone differentiation
(Osteocalcin) marker expres-
sion after 26 days under oste-
ogenic differentiation
conditions on nanofibrous
matrix (Nano), solid films
(Solid), and gelatin-coated tis-
sue culture plastic (Control).
Scale bar¼ 50 mm. Color
images available online at
www.liebertonline.com=ten.
OSTEOGENIC DIFFERENTIATION OF ESC BY NANOFIBERS 1861
mRNA and mineralization data, this indicates that a more
mature osteogenic cell population has differentiated on the
NF matrix than on either the solid films or the control
surface, suggesting that the NF matrix promotes greater
differentiation of ESC toward the osteogenic lineage than the
solid films or control surface.
Discussion
The controlled differentiation of ESC is a necessary first
step in using them as a cell source for tissue engineering
applications.30 Current attempts focus on the use of bio-
chemical factors to direct the differentiation of the cells to a
particular lineage. However, biochemical cues are only part
of the complex environment, which controls lineage fate
in vivo. To elicit more control over lineage fate, one must
move beyond chemical cues and examine how other com-
ponents contribute. In this study, we have examined the ef-
fects of NF architecture on ESC differentiation using thin
PLLA NF matrices as a model for tissue engineering appli-
cations.
With osteoblasts and their precursors, it has been shown
that substrate architecture independent of material chemistry
can significantly affect cellular behavior.31–33 Osteoblasts in
short-term culture on materials with NF architecture have
been shown to extend more processes than osteoblasts cul-
tured on material with solid architecture.34 This is consistent
with the enhanced ESC spreading and process outgrowth
observed after 12 h on NF matrices compared to solid films.
This is significant because the solid films were made of the
same polymer, indicating that the NF architecture was con-
tributing to the difference in cellular response and not the
polymer itself. The increased cell spreading and process
outgrowth with the NF matrices compared to the solid films
may lead to increased activation of signaling pathways af-
fecting lineage fate and the type of tissue formed.
As culture time increased, ESC on NF matrices with oste-
ogenic supplementation continued to exhibit increased dif-
ferentiation toward bone compared to ESC on the solid films.
Increased differentiation on NF architecture compared to
solid architecture has also been observed with osteoblasts.20,34
In addition to the size scale of the material architecture,
increased matrix rigidity have been reported to increased
osteogenic differentiation of preosteoblastic cells.32–34
Several factors likely contribute to the differences in dif-
ferentiation observed between the NF matrices and the solid
films. Similar to the thin matrices and films (Fig. 4), previous
work with macroporous NF PLLA scaffolds formed by a
similar phase separation process showed that NF scaffolds
adsorbed more serum proteins than solid-walled scaffolds
and that the profile of the adsorbed proteins was different
from those adsorbed by the solid-walled scaffolds.19 Differ-
ences in the amount or type of adsorbed serum proteins may
provide a better niche for directing the differentiation of ESC.
Previously, we reported that similar NF scaffolds adsorb
nearly four times more fibronectin than their solid counter-
parts.19 Increased fibronectin adsorbed to the NF matrices
may accelerate ESC differentiation to the mesodermal and
osteogenic lineages on the NF matrices compared to the solid
films, which is further supported by our a5 blocking results.
Increased integrin signaling and differentiation have been
observed in ESC cultured on fibronectin.28 Fibronectin is the
earliest of the matrix proteins synthesized by osteoblasts.35,36
During embryonic development, integrin–fibronectin inter-
actions have been shown to be important to early mesoder-
mal development.37
A previous study found increased b1 integrin expression
and osteogenic differentiation in neonatal mouse osteoblasts
on NF scaffolds compared to their solid counterparts.34 b1
Integrin expression is upregulated in a similar manner on the
thin NF matrices compared to the solid films, which is con-
sistent with the increased osteogenic differentiation and
consistent with the observation that b1 integrin plays a
role in mesodermal lineage commitment of ESC.24 As such,
increased stimulation of b1 integrin, which has been shown
to regulate ESC differentiation through the MAP kinase
signaling pathway,38,39 could also be contributing to this
increased ESC differentiation on the NF matrices compared
to the solid films.
The NF matrices themselves mimic the fiber diameter of
type I collagen, a major component of the bone ECM.27 a2b1
Integrin is the major type I collagen binding integrin.40,41
Although a2 integrin expression is developmentally regu-
lated,26 its upregulation has been linked to a increase in ESC
differentiation28 and is necessary for osteogenic differentia-
tion23,27 as seen in our a2 integrin blocking data (Fig. 3). A
study of neonatal mouse osteoblasts on NF scaffolds indi-
cates that a2b1 integrin could directly interact with the na-
nofibers based on their unaltered expression when collagen
fiber formation was blocked.34 Additionally, preosteoblasts
were found to have unaltered cytoskeleton structure (in
terms of stress fiber and focal adhesion formation) on gelatin-
modified and -unmodified NF matrices.42 As both elimi-
nating the cell-produced collagen fibers and providing a
collagen-like surface chemistry on the NF matrices did not
eliminate or induce the NF effect, the NF architecture itself
could be influencing cell behavior directly in a manner
similar to type I collagen.
Conclusions
These results indicate that NF architecture contributes to
promoting the osteogenic lineage fate of ESC cells. We ob-
served morphological differences in ESC cultured on NF
matrices compared to solid films in short time frames and
increased differentiation to the mesodermal and osteogenic
lineage (osteogenic media) over longer time frames. Based on
these results, we believe that NF architecture plays an
important role in differentiation and should be used in
combination with soluble factors to achieve the directed
differentiation necessary for tissue engineering applications.
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